-
1 Comment
Healthia Limited is currently in a long term uptrend where the price is trading 27.7% above its 200 day moving average.
From a valuation standpoint, the stock is 99.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.2.
Healthia Limited's total revenue rose by 37.4% to $61M since the same quarter in the previous year.
Its net income has increased by 632.8% to $5M since the same quarter in the previous year.
Finally, its free cash flow grew by 298.3% to $9M since the same quarter in the previous year.
Based on the above factors, Healthia Limited gets an overall score of 5/5.
Exchange | AU |
---|---|
CurrencyCode | AUD |
ISIN | AU0000021693 |
Sector | Healthcare |
Industry | Medical Care Facilities |
Market Cap | 252M |
---|---|
PE Ratio | 35.9 |
Target Price | 1.8 |
Dividend Yield | 2.1% |
Beta | 1.02 |
Healthia Limited provides health services in Australia. It operates through three segments: Feet & Ankles; Bodies & Minds; and Eyes & Ears. The company operates podiatry and retail footwear; physiotherapy, hand therapy, occupational therapy, exercise physiology, and speech pathology clinics; and optometry and audiology stores, as well as manufactures and sells orthotic devices. It also offers foot care services, hand and upper limb therapies, orthopaedic, optometry, audiology, pilates, custom orthotic manufacturing services, and medical products to podiatrists, hospitals, medical centres, nursing homes, and allied health professionals. Healthia Limited was incorporated in 2018 and is based in Bowen Hills, Australia.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for HLA.AU using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025